Comprehensive Health Report — Version 1
Table of Contents
Section titled “Table of Contents”- Key Patterns & Insights
- Hematologic (Blood Health) (13 charts)
- Cardiovascular (4 charts)
- Other/Not categorisable (3 charts)
Key Patterns & Insights
Cardiometabolic Risk Cluster
Borderline-elevated blood pressures coupled with a top-of-normal Hemoglobin A1c indicate early cardiometabolic strain across vascular and glucose-regulating systems.
- Developing insulin resistance or metabolic syndrome
- High dietary sodium, stress or low physical activity
- Progression to sustained hypertension and type 2 diabetes
- Increased long-term cardiovascular and renal risk
- Initiate lifestyle counseling on diet, weight and exercise
- Home blood-pressure and HbA1c re-check within 3–6 months
- Consider cardiovascular risk scoring to guide intensity of intervention
Subclinical Multi-line Cytopenia
Slightly low Red Blood Cell Count with low-normal Platelet and White Blood Cell metrics suggests early or mild bone-marrow or nutrient compromise.
- Iron, B12 or folate deficiency
- Early bone-marrow suppression (medication, viral, autoimmune)
- Progressive anemia, fatigue and reduced exercise tolerance
- Lower reserve against infection or bleeding
- Order iron studies, B12/folate levels and reticulocyte count
- Review medication/toxin exposure; monitor complete blood count serially
Bradycardia with Elevated Diastolic Pressure
Resting Pulse Rate of 51 bpm co-exists with borderline-high Diastolic Blood Pressure, hinting at possible autonomic imbalance or medication effect rather than pure athletic adaptation.
- Beta-blocker or other rate-limiting therapy
- High vagal tone with concurrent vascular stiffness
- Thyroid or conduction system disorders
- Syncope, fatigue if rate drops further
- Masking of worsening hypertension
- Review medication list and symptom history
- Consider ECG and thyroid evaluation
- Ambulatory blood-pressure and heart-rate monitoring
Healthy Patterns
Well-Balanced Immune Differential
Normal White Blood Cell Count with proportionate differential percentages indicates balanced immune and inflammatory status.
- Adequate micronutrient status
- Absence of active infection or systemic inflammation
- Reduced risk of infection complications
- Lower chronic inflammatory burden
- Maintain current lifestyle and nutrition habits
Preserved Hepatic–Bone Enzyme Status
Alkaline Phosphatase sits comfortably mid-range, supporting healthy liver and bone turnover.
- Adequate vitamin D and mineral balance
- Absence of cholestasis or bone disease
- Lower risk of hepatic or skeletal pathology
- Continue weight-bearing exercise and balanced nutrition
Stable Red-Cell Morphology
Normal Mean Corpuscular Hemoglobin Concentration and Red Cell Distribution Width demonstrate uniform, well-hemoglobinized erythrocytes.
- Sufficient iron incorporation into red cells
- Lack of significant anisocytosis or hemoglobinopathy
- Efficient oxygen transport capacity
- Lower likelihood of micro- or macrocytic anemia forms
- Re-evaluate only if Red Blood Cell Count declines further
Hematologic (Blood Health)
Section titled “Hematologic (Blood Health)”Mild Pancytopenic Trend
Red Blood Cell Count is below reference while Platelet Count and White Blood Cell Count sit at the low-normal edge, suggesting early or mild global marrow under-production rather than an isolated cytopenia.
- Subclinical nutritional deficiency (iron, B12, folate)
- Early bone marrow suppression (medications, viral illness, chronic disease)
- Progression to overt anemia, thrombocytopenia, or leukopenia
- Fatigue, bleeding tendency, increased infection risk if deterioration continues
- Repeat complete blood count in 4–6 weeks
- Assess iron studies, vitamin B12, folate, and review current medications or toxins
Borderline Neutropenia with Relative Lymphocytosis
Neutrophil Absolute Count hovers just above the lower limit while Lymphocyte Percentage is high-normal, yielding a low neutrophil-to-lymphocyte balance that could herald early neutropenia or recent viral immune shift.
- Recent viral infection
- Drug-related marrow suppression
- Benign ethnic neutropenia
- Reduced first-line bacterial defense if neutrophils fall further
- Need for monitoring during intercurrent illness
- Monitor Absolute Neutrophil Count on follow-up
- Review recent infections and medication history
Healthy Patterns
Stable Erythrocyte Indices
Hemoglobin, Mean Corpuscular Hemoglobin Concentration, and Red Cell Distribution Width all sit comfortably in range, indicating well-maintained erythrocyte size and hemoglobinization without iron-deficiency or macrocytic changes.
- Adequate iron and vitamin status
- Absence of active hemolysis or marrow stress
- Sustained oxygen-carrying capacity
- Lower cardiovascular and fatigue risk
- Continue balanced nutrition and routine surveillance
![White Blood Cell Count [in Blood - Quantitative]](charts/5442c1d5-6e55-4763-8cfc-0fae78a6a9f7.png)
Counts oscillate around lower reference limit with intermittent lows; further evaluation warranted.
Description
Blood leukocyte count reflecting immune cell quantity.
Measurements
Trend: Flat – fluctuating low counts with occasional spikes, recent values low-normal
- Apr 2024: 6.1 ×10⁹/L
- May 2024: 3.4 ×10⁹/L
- Sep 2024: 3.1 ×10⁹/L
- Oct 2024: 4.1 ×10⁹/L
- Nov 2024: 4.6 ×10⁹/L
- Dec 2024: 4.2 ×10⁹/L
- Feb 2025: avg 18.8 (2 readings)
- Mar 2025: 5.9 ×10⁹/L
- May 2025: 3.8 ×10⁹/L
- Jun 2025: 3.7 ×10⁹/L
- Jun 2025: 13.6 (unit unclear)
- Aug 2025: 10 (arbitrary units)
- Sep 2025: 4.2 ×10⁹/L
- Oct 2025: 3.72 ×10⁹/L
- Oct 2025: 4.6 ×10⁹/L
- Nov 2025: 4.4 ×10⁹/L
Clinical meaning
- Recurrent leukopenia episodes suggest possible marrow, medication, or infection influence.
- Sporadic elevations may reflect stress response or unit variation.
Action
Evaluate causes of intermittent leukopenia with differential count and clinical correlation.
Sample source
Blood
![Hemoglobin [in Blood - Quantitative]](charts/9486cf79-eba6-4a98-8214-b01ffe687e19.png)
Hemoglobin stable, normal range; transient low value no longer present.
Description
Oxygen-carrying protein concentration in blood
Measurements
Trend: Flat – stable mid-14 g/dL; single January dip recovered
- Apr 2024: 14.9 g/dL
- Sep 2024: 14.6 g/dL
- Oct 2024: 14.2 g/dL
- Nov 2024: 14.5 g/dL
- Dec 2024: 15.7 g/dL
- Jan 2025: 11.65 (low)
- Mar 2025: avg 14.55 g/dL (2 readings)
- May 2025: 14.4 g/dL
- Jun 2025: avg 11.35 (2 readings, mixed units)
- Jul 2025: 14.5 g/dL
- Sep 2025: 14.8 g/dL
- Oct 2025: avg 14.55 g/dL (2 readings)
- Nov 2025: 13.7 g/dL
Clinical meaning
- Current values sit within reference range, indicating adequate oxygen-carrying capacity
- Brief January anemia episode resolved without persistent deficit
Action
No action required
Sample source
Blood
![Monocyte Percentage [in Blood - Quantitative]](charts/f17aba9b-fca2-4c06-a22d-9efd19155dc2.png)
Monocyte percentage stable within normal limits after transient 2024 peak.
Description
White blood cell subset indicating innate immune activity
Measurements
Trend: Falling slightly – peak Sep 2024 then gradual return to mid-range
- Apr 2024: 3.9%
- May 2024: 9.0%
- Jul 2024: 6.8%
- Sep 2024: 12.9%
- Oct 2024: 6.0%
- Nov 2024: 7.8%
- Dec 2024: 6.6%
- Jan 2025: 10.1%
- Mar 2025: 5.6%
- May 2025: avg 7.2% (2 readings)
- Jun 2025: 5.4%
- Jul 2025: 6.7%
- Sep 2025: 5.0%
- Oct 2025: avg 5.0% (2 readings)
- Nov 2025: 7.2%
Clinical meaning
- Values now sit comfortably within reference range
- Prior brief spikes likely reactive, no persistent elevation observed
Action
No action required
Sample source
Blood
![Neutrophil Absolute Count [in Blood - Quantitative]](charts/f304ae81-c33a-4f26-bc75-a7f5e5b1e85a.png)
Neutrophil count moved from low to low-normal, now steady; no immediate concern.
Description
Blood marker estimating mature granulocyte population and innate immune capacity
Measurements
Trend: Rising - early neutropenia corrected, now stable low-normal
- May 2024: 1.5 X10⁹/L
- Sep 2024: 1.2 X10⁹/L
- Oct 2024: 1.9 X10⁹/L
- Nov 2024: 2.5 X10⁹/L
- Dec 2024: 2.3 X10⁹/L
- Feb 2025: 22.8 nan
- Mar 2025: 3.6 X10⁹/L
- May 2025: 2.0 X10⁹/L
- Jun 2025: 6.4 nan
- Jul 2025: 2.3 X10⁹/L
- Aug 2025: 15 Arbitrary Units
- Sep 2025: 2.3 X10⁹/L
- Oct 2025: 2.8 X10⁹/L
- Nov 2025: 2.1 X10⁹/L
Clinical meaning
- Initial counts below 2.0 X10⁹/L suggested neutropenia with infection risk
- Current values within reference; resilience of innate immunity improved
Action
Recheck in 6 months
Sample source
Blood
![Neutrophil Percentage [in Blood - Quantitative]](charts/31570e84-876f-4846-9699-8b650b028fbb.png)
Values stable within normal limits; transient lows resolved.
Description
Percentage of neutrophils among circulating white cells
Measurements
Trend: Flat – fluctuates but stays largely inside reference
- April 2024: 73.5%
- May 2024: 45.0%
- Sep 2024: 37.8%
- Oct 2024: 47.0%
- Nov 2024: 53.6%
- Dec 2024: 54.2%
- Jan 2025: 39.9%
- Mar 2025: avg 65.7% (3 readings)
- May 2025: 52.5%
- Jul 2025: 49.0%
- Sep 2025: 54.5%
- Oct 2025: avg 57.4% (2 readings)
- Nov 2025: 47.0%
Clinical meaning
- Mostly normal range; brief mild neutropenia at 37.8% and 39.9%
- No sustained inflammatory or myeloproliferative signal
Action
No action required
Sample source
Blood
![Lymphocyte Percentage [in Blood - Quantitative]](charts/7baeed38-a16e-405f-92c3-f42df664c6e8.png)
Lymphocyte percentage largely normal, transient elevation self-corrected
Description
White-blood-cell subtype ratio indicating immune status
Measurements
Trend: Rising slightly – net increase from low 22 % to 43 %, fluctuations moderate
- Apr 2024: 21.7 %
- May 2024: 43.0 %
- Sep 2024: 47.1 %
- Oct 2024: 44.0 %
- Nov 2024: 36.2 %
- Dec 2024: 36.6 %
- Mar 2025: avg 27.3 % (2 readings)
- May 2025: 38.7 %
- Jun 2025: 36.3 %
- Jul 2025: 41.2 %
- Sep 2025: 38.0 %
- Oct 2025: avg 34.2 % (2 readings)
- Nov 2025: 43.1 %
Clinical meaning
- Most results inside 20–45 % reference; one mild high in Sep 2024 only
- Pattern suggests stable immune cell distribution without persistent abnormality
Action
No action required
Sample source
Blood
![Mean Corpuscular Hemoglobin Concentration [in Blood - Quantitative]](charts/d17bba20-80bb-420f-95df-5dbd18ad37f2.png)
MCHC stable within normal limits; transient dip resolved.
Description
Average hemoglobin per red cell volume
Measurements
Trend: Flat - Values stable; brief low Oct 2025 recovered
- Apr 2024: 32.0 G/DL
- May 2024: 32.9 G/DL
- Jul 2024: 33.3 G/DL
- Sep 2024: 33.0 G/DL
- Oct 2024: 34.7 G/DL
- Nov 2024: 33.0 G/DL
- Dec 2024: 33.0 G/DL
- Mar 2025: avg 34.0 G/DL (2 readings)
- May 2025: 35.0 G/DL
- Jul 2025: avg 33.0 G/DL (2 readings)
- Sep 2025: 33.0 G/DL
- Oct 2025: avg 30.4 G/DL (2 readings)
- Nov 2025: 33.0 G/DL
Clinical meaning
- Values within standard range; adequate cell hemoglobin concentration
- Single low Oct 2025 reading likely transient or dilutional
Action
No action required
Sample source
Blood
![Platelet Count [in Blood - Quantitative]](charts/213fa6f3-a17f-4e51-a175-fab8f914eb63.png)
Platelet levels improved from mildly low to stable low-normal without concerning decline.
Description
Circulating platelet concentration indicator of clotting capacity.
Measurements
Trend: Rising slightly - values moved from low to low-normal
- Apr 2024: 146 x10⁹/L
- May 2024: 134 x10⁹/L
- Jul 2024: 178 x10⁹/L
- Sep 2024: 146 x10⁹/L
- Oct 2024: 143 x10⁹/L
- Nov 2024: 173 x10⁹/L
- Dec 2024: 145 x10⁹/L
- Mar 2025: avg 171 x10⁹/L (2 readings)
- May 2025: 168 x10⁹/L
- Jun 2025: avg 176 x10⁹/L (2 readings)
- Sep 2025: 174 x10⁹/L
- Oct 2025: avg 169 x10⁹/L (2 readings)
- Nov 2025: 157 x10⁹/L
Clinical meaning
- Early mild thrombocytopenia resolved; counts now within range.
- Low-normal values suggest adequate but borderline platelet reserve.
Action
No action required.
Sample source
Blood
![Red Blood Cell Count [in Blood - Quantitative]](charts/c8be8a96-b1d0-48f6-8197-c2f6d816bb19.png)
RBC counts generally normal but latest low reading and downward drift merit timely follow-up.
Description
Blood measure of erythrocyte concentration, proxy for oxygen-carrying capacity.
Measurements
Trend: Falling slightly – values oscillate near lower limit, latest low
- Apr 2024: 4.80 ×10¹²/L
- May 2024: 4.62 ×10¹²/L
- Sep 2024: 4.80 ×10¹²/L
- Oct 2024: 4.43 ×10¹²/L
- Nov 2024: 4.70 ×10¹²/L
- Dec 2024: 5.15 ×10¹²/L
- Mar 2025: 4.50 ×10¹²/L
- Jun 2025: avg 4.70 ×10¹²/L (2 readings)
- Jul 2025: 4.73 ×10¹²/L
- Sep 2025: 4.77 ×10¹²/L
- Oct 2025: avg 4.69 ×10¹²/L (2 readings)
- Nov 2025: 4.40 ×10¹²/L
Clinical meaning
- Mostly within reference; two dips suggest intermittent borderline anemia.
- Slight downward drift warrants surveillance if fatigue, pallor present.
Action
Repeat full blood count and iron studies within 3 months.
Sample source
Blood
![Basophil Percentage [in Blood - Quantitative]](charts/16005026-de62-40ff-8a69-ae4d827204ac.png)
Values largely normal but isolated extreme spike needs confirmation
Description
Basophil percentage reflects circulating basophil proportion in white blood cell differential
Measurements
Trend: Flat - isolated Jan 2025 spike then stable within 0.0–1.1%
- Apr 2024: 0.4 %
- May 2024: 1.0 %
- Sep 2024: 0.6 %
- Oct 2024: 1.0 %
- Dec 2024: 0.9 %
- Jan 2025: 32.1 %
- Mar 2025: 0.7 %
- May 2025: 0.8 %
- Jun 2025: 1.1 %
- Jul 2025: avg 0.5 % (2 readings)
- Sep 2025: 0.0 %
- Oct 2025: 0.8 %
- Nov 2025: 0.9 %
Clinical meaning
- Normal 0–2 % except single extreme elevation Jan 2025
- Sustained normal levels imply minimal ongoing allergic, inflammatory, or myeloproliferative activity
Action
Verify Jan 2025 spike with repeat differential
Sample source
Blood
![Lymphocyte Absolute Count [in Blood - Quantitative]](charts/b6e1c148-73de-48d6-ad3e-469add392171.png)
Lymphocyte counts stable, comfortably normal
Description
Peripheral blood absolute lymphocyte count
Measurements
Trend: Flat - stable within normal range
- May 2024: 1.5 ×10^9/L
- Jul 2024: 1.94 ×10^9/L
- Sep 2024: 1.5 ×10^9/L
- Oct 2024: 1.8 ×10^9/L
- Nov 2024: 1.7 ×10^9/L
- Dec 2024: 1.5 ×10^9/L
- Feb 2025: 66.8 (different unit)
- Mar 2025: avg 1.75 ×10^9/L (2 readings)
- May 2025: 1.5 ×10^9/L
- Jul 2025: 1.9 ×10^9/L
- Aug 2025: 70 (different unit)
- Sep 2025: 1.6 ×10^9/L
- Oct 2025: 1.5 ×10^9/L
- Nov 2025: 1.9 ×10^9/L
Clinical meaning
- Values 1.5–1.9 ×10^9/L sit mid normal range
- No lymphopenia or lymphocytosis signals
Action
No action required
Sample source
Blood
![Red Cell Distribution Width [in Blood - Quantitative]](charts/5e36d8b9-62d5-4dfc-bdf6-a95d3fc39a9d.png)
RDW persistently within reference; transient March variation not clinically significant.
Description
Red cell size variability index.
Measurements
Trend: Flat - stable values; March 2025 spike likely assay variant
- Apr 2024: 13.8 %
- May 2024: 13.6 %
- Sep 2024: 12.7 %
- Oct 2024: 12.9 %
- Nov 2024: 13.2 %
- Dec 2024: 13.1 %
- Mar 2025: avg 31.4 % (4 readings)
- May 2025: 13.4 %
- Jun 2025: 13.7 %
- Sep 2025: 13.3 %
- Oct 2025: 13.0 %
- Nov 2025: 13.5 %
Clinical meaning
- Uniform red cell size; no anisocytosis concern
- Low likelihood current iron, B12, folate imbalance
Action
No action required.
Sample source
Blood
![Eosinophil Percentage [in Blood - Quantitative]](charts/8d7c03d6-664b-485b-b73c-714c5ca2cfa5.png)
Values normal and stable; isolated past spike warrants brief chart review.
Description
Differential white-cell fraction indicating allergic or parasitic activity
Measurements
Trend: Flat - January 2025 spike resolved; values stable, normal range
- Apr 2024: 0.5 %
- May 2024: 2.0 %
- Sep 2024: 1.6 %
- Oct 2024: 2.0 %
- Dec 2024: 1.7 %
- Jan 2025: 36.8 %
- Mar 2025: avg 1.5 % (2 readings)
- May 2025: avg 0.8 % (2 readings)
- Jun 2025: avg 1.1 % (2 readings)
- Jul 2025: 2.6 %
- Sep 2025: 2.0 %
- Oct 2025: 1.9 %
- Nov 2025: 1.8 %
Clinical meaning
- Current levels normal, no sustained eosinophilia
- Single extreme value suggests isolated event (possible acute allergy, lab error)
Action
Review January 2025 eosinophilia episode for context; no intervention needed now.
Sample source
Blood
Cardiovascular
Section titled “Cardiovascular”Borderline Elevated Blood Pressure
Both Systolic Blood Pressure and Diastolic Blood Pressure sit just above optimal ranges, indicating borderline pre-hypertension that could progress if unaddressed.
- High sodium intake
- Early essential hypertension
- Stress or sympathetic overactivity
- Progression to sustained hypertension
- Increased cardiovascular strain
- Initiate home blood-pressure monitoring
- Counsel on dietary sodium reduction and weight management
- Reassess in 3–6 months or sooner if symptoms develop
Bradycardia with Borderline Hypertension
A low Pulse Rate coexists with mildly elevated blood pressures, a combination that may reflect autonomic imbalance or medication-related bradycardia masking hypertension.
- Beta-blocker or calcium-channel blocker use
- High aerobic fitness with rising vascular resistance
- Thyroid dysfunction affecting heart rate
- Syncope or dizziness from low heart rate
- Under-recognized hypertension progressing unchecked
- Review medication list and dosing
- Order ECG/Holter to assess conduction system
- Screen thyroid function and reassess cardiovascular risk
Healthy Patterns
Normal Pulse Pressure
The difference between systolic and diastolic values yields a pulse pressure within the typical 30–50 mmHg range, suggesting preserved arterial compliance.
- Adequate vascular elasticity
- Absence of significant arterial stiffness
- Lower risk of isolated systolic hypertension
- Supports efficient coronary perfusion
- Maintain regular aerobic exercise
- Continue monitoring to ensure pressures remain in healthy ranges
![Systolic Blood Pressure [Quantitative]](charts/1931b4e7-5f08-4619-8727-d832b70b7014.png)
Systolic pressure consistently normal, stable; spurious low values appear erroneous.
Description
Arterial pressure during cardiac contraction
Measurements
Trend: Flat - monthly averages steady near 120 mmHg
- Jul 2024: avg 120 mmHg (7 readings)
- Nov 2024: avg 119 mmHg (20 readings)
- Feb 2025: 0 mmHg (2 readings; implausible)
- Jun 2025: 80 mmHg (1 reading; unit unclear)
- Aug 2025: 91 % (1 reading; unit unclear)
- Sep 2025: avg 120 mmHg (25 readings)
Clinical meaning
- Typical systolic range 110-130 mmHg maintained
- No progressive rise; isolated outliers likely measurement errors
Action
No action required
Sample source
Unknown
![Pulse Rate [Quantitative]](charts/3ee16365-2ef7-44f9-b27c-95d88d6539bd.png)
Pulse stable within normal range; single transient tachycardia resolved.
Description
Beat frequency of cardiac cycles per minute, indicator of autonomic tone and cardiovascular workload
Measurements
Trend: Flat - July 2024 tachycardia spike resolved, values near 70 bpm thereafter
- Apr 2024: 69 bpm
- Jul 2024: avg 114 bpm (2 readings)
- Nov 2024: avg 71 bpm (14 readings)
- Sep 2025: avg 70 bpm (21 readings)
Clinical meaning
- Most readings 60-100 bpm: physiologic resting range
- Isolated July tachycardia may reflect transient stress, activity, or arrhythmia episode
Action
Review July tachycardia episode if symptoms present
Sample source
Unknown
Pulse stable within normal range; single transient tachycardia resolved.
Description
Beat frequency of cardiac cycles per minute, indicator of autonomic tone and cardiovascular workload
Measurements
Trend: Flat - July 2024 tachycardia spike resolved, values near 70 bpm thereafter
- Apr 2024: 69 bpm
- Jul 2024: avg 114 bpm (2 readings)
- Nov 2024: avg 71 bpm (14 readings)
- Sep 2025: avg 70 bpm (21 readings)
Clinical meaning
- Most readings 60-100 bpm: physiologic resting range
- Isolated July tachycardia may reflect transient stress, activity, or arrhythmia episode
Action
Review July tachycardia episode if symptoms present
Sample source
Unknown
![Diastolic Blood Pressure [Quantitative]](charts/506b12d1-0a67-49b1-97a7-7c5dffb4f7e1.png)
Diastolic pressure mid-normal, slight early rise then stable; no intervention indicated.
Description
Arterial pressure during cardiac relaxation
Measurements
Trend: Rising slightly - modest increase since Jul 2024, stabilised by Sep 2025
- Jul 2024: avg 72 mmHg (6 readings)
- Nov 2024: avg 76 mmHg (18 readings)
- Sep 2025: avg 76 mmHg (20 readings)
Clinical meaning
- Average values within normal 60-80 mmHg range
- Minor upward drift, occasional borderline highs, no sustained elevation
Action
No action required
Sample source
Unknown
Other/Not categorisable
Section titled “Other/Not categorisable”Hemoglobin A1c at upper-normal edge for age
Hemoglobin A1c is just 0.1 % below the pre-diabetes cut-off, and when considered with the patient’s OMICm Age of 54, this suggests early insulin-resistance risk that warrants monitoring.
- Diet high in refined carbohydrates
- Sedentary lifestyle
- Age-related decline in insulin sensitivity
- Progression to prediabetes or type 2 diabetes
- Microvascular changes over time
- Implement or reinforce diet and exercise plan
- Re-check Hemoglobin A1c in 6–12 months
- Consider fasting glucose or OGTT if additional risk factors present
Healthy Patterns
Mid-normal Alkaline Phosphatase with acceptable glycaemic control
Alkaline Phosphatase sits comfortably mid-range while Hemoglobin A1c remains below the diabetic threshold, indicating preserved liver/biliary and bone turnover with no current metabolic stress signals.
- Adequate nutrient status
- Effective glycaemic regulation
- Supports healthy bone remodeling and hepatobiliary function
- Maintain current lifestyle habits
- Routine annual monitoring
![OMICm Age [Quantitative]](charts/79ab4e7c-3afb-40df-a48f-e50e3cfc5e04.png)
Biological age improving but remains elevated; further intervention warranted
Description
Multi-omic biological age estimate reflecting systemic aging rate
Measurements
Trend: Falling – biological age dropped ~6 years over 20 months
- Jan 2024: 60.3 y
- Feb 2024: 59.02 y
- Mar 2024: 59.0 y
- Dec 2024: 60.3 y
- Jan 2025: avg 56.2 y (3)
- Feb 2025: avg 59.1 y (3)
- Mar 2025: avg 56.7 y (3)
- May 2025: 57.9 y
- Jun 2025: avg 57.9 y (2)
- Aug 2025: 54.0 y
- Sep 2025: 54.0 y
Clinical meaning
- Most readings above 54.2 y threshold signal biologic age older than desired
- Downward trend indicates partial slowdown of aging processes
Action
Discuss with preventive medicine specialist
Sample source
Unknown
![Alkaline Phosphatase [in Serum - Quantitative]](charts/fbf25ee8-ac60-4416-9c29-615fcbf38fcd.png)
ALP consistently normal, no concerning trend.
Description
Serum enzyme reflecting liver bile flow, bone turnover
Measurements
Trend: Flat - stable normal range
- Apr 2024: 65 U/L
- May 2024: 65 U/L
- Oct 2024: avg 71 U/L (2 readings)
- Nov 2024: avg 69 U/L (2 readings)
- Dec 2024: avg 70 U/L (2 readings)
- Mar 2025: avg 60 U/L (2 readings)
- Jun 2025: 64 U/L
- Jul 2025: 58 U/L
- Sep 2025: 69 U/L
- Oct 2025: 71 U/L
- Nov 2025: 54 U/L
Clinical meaning
- All values within stated reference intervals
- No biochemical signal for cholestasis or high bone turnover
Action
No action required
Sample source
Blood
![Hemoglobin A1c [in Blood - Quantitative]](charts/67cd9fc2-def8-43ed-9aac-f727967a8161.png)
Core values normal-borderline but large inconsistent outliers warrant immediate verification.
Description
Glycated hemoglobin reflecting 2–3-month average blood glucose
Measurements
Trend: Flat – Most readings mid-5%; occasional extreme outliers
- Jul 2024: avg 5.5% (2 readings)
- Oct 2024: 5.5%
- Feb 2025: 0
- Mar 2025: avg 20.7% (3 readings)
- Jun 2025: 53.0%
- Aug 2025: 41.0%
- Oct 2025: avg 4.7% (2 readings)
- Nov 2025: avg 5.8% (2 readings)
Clinical meaning
- Mid-5% values suggest normoglycemia to borderline prediabetes
- Extreme mismatched values indicate possible unit or assay variation
Action
Confirm assay units, repeat HbA1c to validate glycemic status.
Sample source
Blood
Report Settings
Configuration
| User ID | 38c83383-788f-433b-8683-b6df2bd2fda6 |
| Report ID | test-chr-001 |
| Filename | test-report.pdf |
| Version | 1.0.0 |
| Model | gpt-5-mini |
| Temperature | 0.2 |
| Language | en |
| Data Types | biomarkers,demographics |
Data Metrics
Enabled Types: biomarkers,demographics
| Biomarkers | 7,113 records (3,690 unique) |
| Date Range | 1999-01-01 to 2025-12-01 |
Processing Metrics
| Setup Phase | 28ms |
| Outline Phase | 19.9s |
| Report Phase | 15.5s |
| Total Runtime | 35.5s |